Genetic variation at selected SNPs in the leptin gene and association of alleles with markers of kidney disease in a Xhosa population of South Africa

PLoS ONE

Volumn 5, Issue 2, 2010, Pages

  Okpechi, Ikechi G ^a   Rayner, Brian L ^a   Van Der Merwe, Lize ^b   Mayosi, Bongani M ^a   Adeyemo, Adebowale ^c   Tiffin, Nicki ^d   Ramesar, Rajkumar ^d  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF THE WESTERN CAPE   (South Africa)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE; LEPTIN;

ADULT; ALLELE; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; DISEASE MARKER; GENETIC VARIABILITY; GENOTYPE; GLOMERULUS FILTRATION RATE; HAPLOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH AFRICA; ALBUMINURIA; BLOOD; CHRONIC DISEASE; ETHNOLOGY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; GENETICS; KIDNEY DISEASE; MALE; MIDDLE AGED; NEGRO; NUCLEOTIDE SEQUENCE; URINE;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ALBUMINURIA; ALLELES; BASE SEQUENCE; CHRONIC DISEASE; CREATININE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; GLOMERULAR FILTRATION RATE; HAPLOTYPES; HUMANS; HYPERTENSION; KIDNEY DISEASES; LEPTIN; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SOUTH AFRICA;

EID: 77949391704     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009086     Document Type: Article

References (30)

1. Lysaght MJ (2002) Maintenance dialysis population dynamics: Current trends and long-term implications. J Am Soc Nephrol 13: 37-40.
2. Xue J, Ma JZ, Louis TA, Collins AJ (2001) Forecast of the number of patients with end-stage renal disease in United States to the year 2010. J Am Soc Nephrol 12: 2753-2758.
3. Wachtell K, Ibsen H, Olsen MH, Borch-Johnsen K, Lindholm LH, et al. (2003) Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med 139: 901-906.
4. Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, et al. (2002) Prevention of Renal and Vascular End Stage Disease (PREVEND) Study Group. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 106: 1777-1782.
5. Santopinto JJ, Fox KA, Goldberg RJ, Budaj A, Piñero G, et al. (2003) on behalf of the GRACE Investigators. Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE). Heart 89: 1003-1008.
6. Coresh J, Wei GL, McQuillan G, Brancati FL, Levey AS, et al. (2001) Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med 161: 1207-1216.
7. Jones CA, Francis ME, Eberhardt MS, Chavers B, Coresh J, et al. (2002) Microalbuminuria in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis 39: 445-459.
8. Stengel B, Tarver-Carr ME, Powe NR, Eberhardt MS, Brancati FL (2003) Lifestyle factors, obesity and the risk of chronic kidney disease. Epidemiology 14: 479-487.
9. Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D (2004) Predictors of new-onset kidney disease in a community-based population. JAMA 291: 844-850.
10. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425-432.
11. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, et al. (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334: 292-295.
12. Strobel A, Issad T, Camoin L, Ozata M, Strosberg AD (1998) A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet 18: 213-215.
13. Rudberg S, Persson B (1998) Serum leptin levels in young females with insulindependent diabetes and the relationship to hyperandrogenicity and microalbuminuria. Horm Res 50: 297-302.
14. Okpechi IG, Pascoe MD, Swanepoel CR, Rayner BL (2007) Microalbuminuria and the metabolic syndrome in non-diabetic black Africans. Diab Vasc Dis Res 4: 365-367.
15. Wolf G, Hamann A, Han DC, Helmchen U, Thaiss F, et al. (1999) Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis. Kidney Int 56: 860-872.
16. Ballerman BJ (1999) A role for leptin in glomerulosclerosis? Kidney Int 56: 1154-1155.
17. Lander ES, Schork NJ (1994) Genetic dissection of complex traits. Science 256: 2037-2048.
18. Levey A, Greene T, Kusek J, Beck G: MDRD Study Group (2001) A simplified equation to predict glomerular filtration rate from serum creatinine [Abstract]. J Am Soc Nephrol 11: 155.
19. Sinnwell JP, Schaid DJ (2008) Haplo Stats (version 1.4.0): Statistical Methods for Haplotypes When Linkage Phase is Ambiguous. Mayo website (2010) http://mayoresearch.mayo.edu/mayo/research/schaid-lab/upload/manualHaploStats. pdf.
20. The International HapMap Project. HapMap website (2010) http://www.hapmap.org.
21. Lucantoni R, Ponti E, Berselli ME, Savia G, Minocci A, et al. (2000) The A19G polymorphism in the 5′ untranslated region of the human obese gene does not affect leptin levels in severely obese patients. J Clin Endocrinol Metab 85: 3589-3591.
22. Skibola CF, Holly EA, Forrest MS, Hubbard A, Bracci PM, et al. (2004) Body Mass Index, Leptin and Leptin Receptor Polymorphisms, and Non-Hodgkin Lymphoma. Cancer Epidemiol Biomarkers Prev 13: 779-786.
23. Shintani M, Ikegami H, Fujisawa T, Kawaguchi Y, Ohishi M, et al. (2002) Leptin gene polymorphism is associated with hypertension independent of obesity. J Clin Endocrinol Metab 87: 2909-2912.
24. Hinuy HM, Hirata MH, Sampaio MF, Armaganijian D, et al. (2006) LEP 3′ HVR is associated with obesity and leptin levels in Brazilian individuals. Molecular Genetics and Metabolism 89: 374-380.
25. Porreca E, Di Febbo C, Pintor S, Baccante G, Gatta V, et al. (2006) Microsatellite polymorphism of the human leptin gene (LEP) and risk of cardiovascular disease. Int J Obes (Lond) 30: 209-213.
26. Gaukrodger N, Mayosi BM, Imrie H, Avery P, Baker M, et al. (2005) A rare variant of the leptin gene has large effects on blood pressure and carotid intima-medial thickness: a study of 1428 individuals in 248 families. J Med Genet 42: 474-478.
27. Briley LP, Szczech LA (2006) Leptin and Renal Disease. Seminars in Dialysis 19: 54-59.
28. Seedat YK (1999) Improvement in treatment of hypertension has not reduced incidence of end-stage renal disease. J Hum Hypertens 13: 747-751.
29. Krop JS, Coresh J, Chambless LE, Shahar E, Watson RL, et al. (1999) A community-based study of explanatory factors for the excess risk for early renal function decline in Blacks vs Whites with diabetes: The Atherosclerosis Risk in Communities Study. Arch Intern Med 159: 1777-1783.
30. Tarver-Carr ME, Powe NR, Eberhardt MS, Laveist TA, Kington RS, et al. (2002) Excess Risk of Chronic Kidney Disease among African-American versus White Subjects in the United States: A Population-Based Study of Potential Explanatory Factors. J Am Soc Nephrol 13: 2363-2370.